TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Cash Flow Statement
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) generated $1.9B of operating cash flow over the twelve months to 2026-06-30, spent $550.0M on capital expenditure and had free cash flow of $1.3B, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TEVATEVA PHARMACEUTICAL INDUSTRIES LTDFollow TEVA — free
—
Price chart with a free account
- Market cap
- 45.9B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3.37 | 4.14 | 4.13 | 4.57 | 3.24 | 2.45 | 0.75 | 1.22 | 0.80 | 1.59 | 1.37 | 1.25 | 1.65 | 1.90 | |
| Capital expenditure | 0.72 | 0.71 | 1.05 | 1.10 | 1.03 | 0.65 | 0.53 | 0.58 | 0.56 | 0.55 | 0.53 | 0.50 | 0.50 | -0.55 | |
| Free cash flow | 2.65 | 3.43 | 3.08 | 3.47 | 2.21 | 1.80 | 0.22 | 0.64 | 0.24 | 1.04 | 0.84 | 0.75 | 1.15 | 1.35 | |
| Dividends paid | 0.53 | 0.67 | 0.80 | 0.86 | 1.09 | 0.01 | — | — | — | — | — | — | — | — | |
| Share repurchases | 0.00 | 0.10 | 0.90 | 1.16 | 0.50 | — | — | — | — | — | — | — | — | — | |
| Stock-based compensation | 0.05 | 0.08 | 0.09 | 0.08 | 0.06 | 0.16 | 0.12 | 0.13 | 0.12 | 0.12 | 0.12 | 0.12 | 0.16 | — |
USD billions · SEC XBRL
TEVA PHARMACEUTICAL INDUSTRIES LTD — questions
- What is TEVA PHARMACEUTICAL INDUSTRIES LTD's operating cash flow?
- $1.9B over the twelve months to 2026-06-30.
- How much does TEVA PHARMACEUTICAL INDUSTRIES LTD spend on capital expenditure?
- $550.0M over the twelve months to 2026-06-30.
- What is TEVA PHARMACEUTICAL INDUSTRIES LTD's free cash flow?
- $1.3B over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from TEVA PHARMACEUTICAL INDUSTRIES LTD's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.